socalTECH

AUGUST 13, 2014

The company is developing treatments for disorders of the inner ear. Otonomy was backed by Avalon Ventures, OrbiMed, Novo A/S, TPG Biotechnology Partners, Domain Associates, and Rivervest Venture Partners. otonomy merger acquisition biotech lifescience otic nasdaq exit' READ MORE>>.

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

NOVEMBER 13, 2019

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124

Avalon San Diego Incubator Technology 124

socalTECH

DECEMBER 2, 2013

The developer of portable oxygen concentrators -- used as an alternative to bulky, oxygen canisters for those with chronic respiratory conditions like COPD -- said it plans to raised up to $86.25M in its public debut. Inogen is venture backed by Novo A/S, Versant Ventures, Arboretum Ventures, Avalon Ventures, AMV Partners, and others.

Avalon 153

Avalon Acquisition Marketing Develop 153

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. and $16.00 READ MORE>>.

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

NOVEMBER 3, 2014

San Diego-based Proximal Data , a developer of storage caching software aimed at use with virtualized systems, has been acquired by Samsung Electronics , Samsung said today. Proximal Data was venture backed by Divergent Ventures and Avalon Ventures, and had only announced around $5M in funding. READ MORE>>.

Avalon 138

Avalon San Diego Software Acquisition 138

socalTECH

APRIL 1, 2013

San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures. The firm is led by Rory Bolt. READ MORE>>.

Software 124

Software Avalon San Diego Design 124

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. in its IPO, and closed up slightly in its first day of trading on Thursday.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

JULY 21, 2011

San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. Amira Pharmaceuticals was venture backed by Avalon Ventures, Novo A/S,Prospect Venture Partners, and Versant Ventures.

Avalon 150

Avalon San Diego Venture Capital Capital 150

Xconomy

FEBRUARY 26, 2020

Takeda (NYSE: TAK ) acquired the company for an undisclosed amount up front, plus up to $330 million in payments based on development and regulatory milestones for PvP’s experimental celiac disease drug KUMA062 (now TAK-062). That day is here. The deal follows completion of a Phase 1 study evaluating the PvP drug.

San Diego 72

San Diego Study Develop Development 72